BioGaia AB (publ)
BIOGY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.45 | 2.41 | -13.33 | 0.27 |
| FCF Yield | 1.00% | 0.89% | 0.33% | 0.91% |
| EV / EBITDA | 106.20 | 66.73 | 84.46 | 82.38 |
| Quality | ||||
| ROIC | 5.23% | 6.89% | 4.06% | 4.42% |
| Gross Margin | 74.24% | 72.62% | 73.27% | 70.87% |
| Cash Conversion Ratio | 1.66 | 0.71 | 0.37 | 1.00 |
| Growth | ||||
| Revenue 3-Year CAGR | -2.77% | 5.88% | 6.17% | 8.82% |
| Free Cash Flow Growth | -85.04% | 117.01% | -65.60% | 4.71% |
| Safety | ||||
| Net Debt / EBITDA | -7.75 | -5.22 | -11.34 | -9.84 |
| Interest Coverage | 25.08 | 42.93 | 46.15 | 10.76 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 5.92 |